“We are very excited to have found this potent neutralizing antibody that we hope will participate in ending the COVID-19 pandemic,” said project co-lead David Veesler, PhD, with the University of Washington in Seattle.

“By examining cognitive dysfunction patterns within an individual, we can develop better risk assessment tools that will allow quick therapeutic interventions before relapses occur,” said co-investigator of the project Olusola Ajilore, MD, PhD, with the University of Illinois at Chicago.